Paxlovid 300-100 MG dose pack UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1QAA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,871
Award facts
- Contract value 100% obligated
- $19,871.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $19,871.47 by the Defense Logistics Agency on January 12, 2026, for Paxlovid 300-100 mg dose packs (30-count units). This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was awarded without a set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The DLA's Medical Supply Chain utilizes this prime vendor vehicle to procure a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally.
This award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems. The company's competitive capability to supply essential medications such as antivirals, specialty pharmaceuticals, and vaccines across multiple therapeutic domains has been demonstrated through numerous prior delivery orders under its master contract vehicle. The rapid completion timeline and firm fixed pricing structure are consistent with the company's standard delivery order execution model for time-sensitive pharmaceutical commodities required by Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F1QAA?
SPE2DR26F1QAA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1QAA worth?
The government has obligated $19,871 on SPE2DR26F1QAA.
Is contract SPE2DR26F1QAA an order under another contract?
Yes. SPE2DR26F1QAA is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1QAA competed?
The extent of competition for SPE2DR26F1QAA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award